1,3-Benzodioxolyl-N-methylpentanamine
1,3-Benzodioxolyl-N-methylpentanamine[edit]
1,3-Benzodioxolyl-N-methylpentanamine, also known as MBDP, is a synthetic compound that belongs to the class of substituted amphetamines. It is structurally related to MDMA and other phenethylamines, and it is known for its psychoactive properties.
Chemical Structure[edit]
MBDP is characterized by the presence of a methylenedioxy group attached to the phenyl ring, which is a common feature in many psychoactive compounds. The chemical structure of MBDP can be described as a phenethylamine core with a methylenedioxy bridge and an N-methylpentanamine side chain.
Pharmacology[edit]
MBDP acts primarily as a serotonin and dopamine releasing agent. It is thought to increase the levels of these neurotransmitters in the brain, leading to its psychoactive effects. The compound is known to produce effects similar to those of MDMA, including euphoria, increased sociability, and enhanced sensory perception.
Effects and Risks[edit]
The effects of MBDP are similar to those of other entactogens, with users reporting feelings of empathy, emotional closeness, and a heightened sense of well-being. However, like many synthetic drugs, MBDP can also pose significant health risks. Potential adverse effects include tachycardia, hypertension, hyperthermia, and serotonin syndrome.
Legal Status[edit]
The legal status of MBDP varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important for researchers and users to be aware of the legal implications of possessing or distributing MBDP.
Related Compounds[edit]
MBDP is part of a larger family of compounds known as substituted methylenedioxyphenethylamines. Other related compounds include MDMA, MDA, and MDEA. These compounds share similar chemical structures and pharmacological effects.
See Also[edit]
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
